Science
New hope for the future
We provide the possible solution of using mitochondrial for treating currently non-treatable diseases.
COMITELL® targets the identified needs in an effective and unique approach to transferring the whole mitochondrion from healthy cells into diseased cells (mitochondrial transplantation):
Maintains the mitochondria bioactivity for up to four weeks.
Significantly improves the intracellular delivery efficiency.
It can be used for mitochondria transplantation/delivery therapy to treat the broad scope of mitochondrial-related diseases.
COMITELL® introduces a fundamental tool that enables mitochondria transplantation-based therapy by offering long-lasting bioactivity and high-efficiency delivery. This unique encapsulation technology has the potential to revolutionize the treatment of various mitochondrial-related diseases, significantly enhancing patient outcomes and quality of life.